Ebola vaccine shows long-term protection over 2 years - Axios

Axios
Ebola vaccine shows long-term protection over 2 years
Axios
An Ebola vaccine made by Merck has protected a group of volunteers for two years — the longest it has been shown to protect against the disease, according to a study published in Lancet Infectious Diseases. The context: "A fast-acting, long-lasting ...